Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 20

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 20
---
  267 |
| INDEX TO FINANCIAL STATEMENTS                                                                               |     |  F-1 |
| ANNEX A — Merger Agreement                                                                                  |     |  A-1 |
| ANNEX B — Proxy Card                                                                                        |     |  B-1 |
| ANNEX C — Proposed Charter and Bylaws of Combined Company                                                   |     |  C-1 |
| ANNEX D — Management Services Agreement by and between Aptorum Therapeutics and DiamiR                      |     |  D-1 |
| ANNEX E — Intellectual Property License Agreement by and between Aptorum, Aptorum Therapeutics and DiamiR   |     |  E-1 |
| ANNEX F — Voting and Support Agreement by and between Aptorum and its major shareholder                     |     |  F-1 |
| ANNEX G — Form of Stockholders Agreement                                                                    |     |  G-1 |
| ANNEX H — Stock Incentive Plan                                                                              |     |  H-1 |
| ANNEX I — Certificate of Designation of the Relative Rights and Preferences of the Series A preferred stock |     |  I-1 |

i TRADEMARKS, SERVICE MARKS AND TRADENAMES This proxy statement/prospectus contains trademarks, service marks and trade names of others, which are the property of their respective owners. Solely for convenience, the trademarks, service marks, logos and trade names referred to in this proxy statement/prospectus are included without the ®and ™ symbols. All trademarks, service marks and trade names appearing in this proxy statement/prospectus are, to our knowledge, the property of their respective owners. We do not intend our use or display of other companies’ trademarks, service marks, copyrights or trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies or unrelated parties. ii QUESTIONS AND ANSWERS ABOUT THE MERGER Except where specifically noted, the following information and all other information contained in this proxy statement/prospectus does not give effect to the proposed share consolidation described in Proposal No. 1 of this proxy statement/prospectus. The following section provides answers to frequently asked questions about the Merger and the Special Meeting. This section, however, provides only summary information. For a more complete response to these questions and for additional information, please refer to the cross -referencedsections. Q:Why am I receiving this proxy statement/prospectus? A:You are receiving this proxy statement/prospectus because you have been identified as a Aptorum